Judgment of the Court (Fourth Chamber) of 3 July 2019
Viridis Pharmaceutical Ltd v European Union Intellectual Property Office
Appeal – EU trade mark – Revocation proceedings – Word mark Boswelan – Genuine use – Absence – Use of the mark in the context of a clinical trial prior to the submission of an application for marketing authorisation for a medicinal product – Proper reason for non-use – Concept
Case C-668/17 P
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Judgment
ECLI:EU:C:2019:557 |
|
|
Opinion
ECLI:EU:C:2019:4 |
|
|